Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

Incyte Corporation (Group)

https://www.incyte.com

	Start	2003-01-01 renamed
	Predecessor	Incyte Genomics (Group)
	Industry	genomics/genetics

	Region	Wilmington, DE
	Country	United States (USA)
	Street	Experimental Station, Route 141 & Henry Clay Road, Bldg. E336
	City	19880 Wilmington, DE
	Tel	+1-302-498-6700
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	34,440,000 (revenue, consolidated (2007) 2007-12-31)
	Profit	-86,881,000 (2007-12-31)
	Cash	257,327,000 (2007-12-31)


		Record changed: 2023-07-10

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Incyte Corporation (Group)

[1] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
[2] MorphoSys AG. (5/3/23). "Press Release: MorphoSys AG Reports First Quarter 2023 Financial Results". Planegg....
[3] MorphoSys AG. (8/26/21). "Press Release: MorphoSys and Incyte Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Plan...
[4] MorphoSys AG. (8/17/21). "Press Release: MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China". Planegg....
[5] Crescendo Biologics Ltd.. (5/10/21). "Press Release: Crescendo Biologics further Strengthens Leadership Team with Appointment of Dr Michael Booth as Chief Financial Officer". Cambridge....
[6] MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE....
[7] iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva....
[8] Eli Lilly and Company. (4/14/17). "Press Release: U.S. FDA Issues Complete Response Letter for Baricitinib". Indianapolis, IN....
[9] Calithera Biosciences, Inc.. (3/16/17). "Press Release: Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights". South San Francisco, CA....
[10] Eli Lilly and Company. (2/13/17). "Press Release: European Commission Approves Once-daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis". Indianapolis, IN....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]